Merril Pharma Private Limited

Merril Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2005PTC046638 Incorporated 22 August 2005 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹66.57 Cr
▲ 25% YoY
Net loss · FY 2025
₹12.31 Lakh
Net margin -0.2%
EBITDA · FY 2025
₹5.22 Cr
EBITDA margin 7.8%
Authorised capital
₹57.25 Lakh
Registered with MCA
Paid-up capital
₹40.1 Lakh
Issued & subscribed
Open charges
₹17.81 Cr
Satisfied ₹16.18 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
157
Provident fund records

About Merril Pharma Private Limited

Data last updated:

Merril Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 August 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2005PTC046638. Its GSTIN is 24AAECM4673L1Z6 (Gujarat). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹57.25 Lakh and a paid-up capital of ₹40.1 Lakh. It is led by directors including Jitendrakumar Raval and Rajendrasingh Jodha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A.402 Empire Business Hub Opp Shakti Farm Science City Road Sola, Ahmedabad, Gujarat, India – 380060.

As per the financials filed for FY 2025, the company reported a revenue of ₹66.57 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹12.31 Lakh (net margin -0.2%) and EBITDA of ₹5.22 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 9% over five years.

The company has about 157 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹17.81 Cr and satisfied charges of ₹16.18 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending.

Merril Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0001326). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website merrilpharma.co.in.

Company details

CIN U24230GJ2005PTC046638
Registration Number 046638
Incorporation Date 22 August 2005
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UK-06-0001326

Recognitions & Rankings of Merril Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-UK-06-0001326

Contact details

Merril Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is merrilpharma.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    A.402 Empire Business Hub Opp Shakti Farm Science City Road Sola, Ahmedabad, Gujarat, India – 380060
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Merril Pharma Private Limited, buy the company report.

Comprehensive company report
Merril Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Merril Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Merril Pharma Private Limited, buy the company report.

Financials of Merril Pharma Private Limited

FY 2025 filings available

Merril Pharma Private Limited reported revenue of ₹66.57 Cr (up 25% YoY) for FY 2025.

Revenue · FY 2025
₹66.57 Cr ▲ 25%
Net loss · FY 2025
₹12.31 Lakh margin -0.2%
EBITDA · FY 2025
₹5.22 Cr margin 7.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 22%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 38%
5 years · compounded
▲ 23%

Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 25% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.22 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹12.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.8%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Merril Pharma Private Limited, buy the company report.

Board of directors of Merril Pharma Private Limited

Merril Pharma has 6 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Jitendrakumar RavalDirector15 May 200620 Years 5 MonthsCurrent
Rajendrasingh JodhaDirector22 Aug 200521 Years 2 MonthsCurrent
Rajendrakumar PatelDirector15 May 200620 Years 5 MonthsCurrent
Bharatkumar PatelDirector22 Aug 200521 Years 2 MonthsCurrent
Vipulkumar Bharatbhai PatelDirector29 Jun 200719 Years 4 MonthsCurrent
Rakeshkumar PatelDirector15 May 200620 Years 5 MonthsCurrent

Peer comparison

Merril Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Premium Serums and Vaccines Private Limited₹67.25 Cr (FY 2025)28.0%Mumbai, Maharashtra, India
Pharmax India Private Limited₹66.65 Cr (FY 2024)2.0%Mumbai, Maharashtra, India
Swefn Pharmaceuticals Private Limited₹66.63 Cr (FY 2025)9.0%Moraiya, Gujarat, India
Merril Pharma Private Limitedthis company₹66.57 Cr (FY 2025)-₹12.31 Lakh-0.2%25.0%157Ahmedabad, Gujarat, India
Hiral Labs Limited₹66.46 Cr (FY 2025)6.0%Ahmedabad, Gujarat, India
Skyec Drugs and Pharmaceuticals Private Limited₹66.27 Cr (FY 2025)19.0%Chennai, Tamil Nadu, India
Medizen Labs Private Limited₹66.2 Cr (FY 2023)39.0%Bangalore, Karnataka, India
Bestochem Formulations (India) Limited₹66.17 Cr (FY 2024)5.0%New Delhi, Delhi, India

To see the full peer comparison of Merril Pharma Private Limited, buy the company report.

Auditor

Merril Pharma Private Limited is audited by C D MODH & CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
C D MODH & COFY 2024120474W

Shareholding

The shareholding of Merril Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Merril Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹17.81 Cr
Satisfied charges
₹16.18 Cr
Breakdown by lending institutions
Others₹10.00 Cr
Axis Bank Limited₹3.92 Cr
Sidbi₹3.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 May 2025101090378Others₹1 LakhOpen
29 Jan 2025101054471Others₹4.79 CrOpen
29 Jan 2025101054608Others₹5.2 CrOpen
23 Mar 2022100549469Sidbi₹89.91 LakhOpen
29 Jul 2020100356093Sidbi₹3 CrOpen

To see the full charge records of Merril Pharma Private Limited, buy the company report.

Total charge records: 11 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Merril Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Merril Pharma Private Limited has a workforce of 157 employees on its EPFO records as of Feb 28, 2025, across 2 active EPFO establishments.

Employee count
157
Active EPFO establishments
2
Employee growth
-2.48%

GST

Merril Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
24AAECM4673L1Z6GujaratActive03 May 2019
05AAECM4673L1Z6UttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Merril Pharma Private Limited, buy the company report.

Recent activity

Merril Pharma Private Limited has 6 board changes on record since 2005: 6 appointments. The latest: Vipulkumar Bharatbhai Patel was appointed as Director on 29 Jun 2007.

AGM
Merril Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 1.00 Lakh with Charge ID 101090378 was registered on 05 May 2025.
Charges
A charge with Others of Rs. 479.00 Lakh registered on 29 Jan 2025 with Charge ID 101054471 was modified on 24 Apr 2025.
Charges
A charge with Others of Rs. 519.60 Lakh registered on 29 Jan 2025 with Charge ID 101054608 was modified on 24 Apr 2025.
Filing
Merril Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 18 Dec 2020 via Charge ID 100399332 with Bank Of India was fully satisfied on 18 Feb 2025.
Charges
A charge with Others amounted to Rs. 479.00 Lakh with Charge ID 101054471 was registered on 29 Jan 2025.
Charges
A charge with Others amounted to Rs. 519.60 Lakh with Charge ID 101054608 was registered on 29 Jan 2025.
Charges
A charge with Bank Of India of Rs. 1,399.54 Lakh registered on 18 Dec 2020 with Charge ID 100399332 was modified on 02 May 2022.
Charges
A charge with Sidbi amounted to Rs. 89.91 Lakh with Charge ID 100549469 was registered on 23 Mar 2022.
Charges
A charge with Bank Of India amounted to Rs. 1,399.54 Lakh with Charge ID 100399332 was registered on 18 Dec 2020.
Charges
A charge registered on 01 May 2018 via Charge ID 100177202 with Others was fully satisfied on 21 Sep 2020.

17 earlier events are in the company report.

Frequently asked questions

Merril Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 August 2005 (21+ years old) and is registered under CIN U24230GJ2005PTC046638.

Merril Pharma has 6 current directors:

The latest financial statements of Merril Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Merril Pharma is 24AAECM4673L1Z6, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAECM4673L1Z6 (Uttarakhand).

The CIN (Corporate Identification Number) of Merril Pharma is U24230GJ2005PTC046638. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Merril Pharma has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.

Merril Pharma was incorporated on 22 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Merril Pharma by revenue are Premium Serums and Vaccines Private Limited, Pharmax India Private Limited, Swefn Pharmaceuticals Private Limited, Hiral Labs Limited, Skyec Drugs and Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Vipulkumar Bharatbhai Patel was appointed as Director on 29 Jun 2007. Jitendrakumar Raval was appointed as Director on 15 May 2006. Rajendrakumar Patel was appointed as Director on 15 May 2006. Merril Pharma has 6 board changes on record in total.

Yes, Merril Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-UK-06-0001326).

Merril Pharma can be reached through the website merrilpharma.co.in. Its registered office is in Ahmedabad, Gujarat, India.